CTRI/2024/12/078715尚未招募不适用
Pharmaceutico-analytical study and clinical evaluation of Tiktadi Ghrita Ointment in Kikkisa with special reference to Striae gravidarum: A Randomized Controlled Trial
Dr Alka Gajanan Khade1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2025年1月10日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 64
- 试验地点
- 1
- 主要终点
- Pharmaceutico-analytical Studies of Tiktadi Ghrita Ointment
研究概览
简要总结
In the present study, total 64 participants will be taken for trial dividing them in 2 equal groups.
Grp-A will receive the trial drug ’Tiktadi Ghrita Ointment’and Grp-B will receive the controlled drug ’Karveer Taila’
for external application for 45 days. Follow up will be taken on Day-15,30,45. Result will be
concluded based on assessment criteria.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 35.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients willingly participating in the trial and giving consent form.
- •â€¢ Selection of patient will be Primigravida only.
- •â€¢ Women diagnosed with symptoms of Kikkisa –
- •Vaivarnya (Discoloration)
- •Kandu (Itching)
- •Vidah(Burning sensation)
- •Rekha Swarupa Twak Sankocha (Linear line marking and contractions of the skin in the abdomen).
排除标准
- •1.Women suffering from any other skin diseases except Kikkisa.
- •2.Known case of any systemic illness like tuberculosis,HIV, Hepatitis B, Hepatitis C, Diabetes mellitus, Hyperbilirubinemia,etc 3.Presence of any surgical scar on the abdomen.
- •4.High-risk pregnancy.
- •(multiple pregnancy, pregnancy induced hypertension, Polyhydramnios, etc.).
结局指标
主要结局
Pharmaceutico-analytical Studies of Tiktadi Ghrita Ointment
时间窗: 6 Months
次要结局
- This study may prove Tiktadi Ghrita Ointment as effective treatment in the management of Kikkisa(Follow up on 15th,30th & 45th Day)
研究者
Dr Alka Gajanan Khade
Shri Ayurveda Mahavidyalaya, Nagpur
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study to evaluate the pharmacokinetics, safety and tolerability of Secukinumab in patients with GCA or PMR2023-507667-19-00Novartis Pharma AG24
招募中
1 期
Study of safety, tolerability, pharmacokinetics and pharmacodynamics of MSD-001 in healthy participants2024-512939-67-00Mindstate Design Labs Inc.68
已完成
1 期
A study to investigate the safety and pharmacological effect of a single intravenous infusion of GSK2857914 in male and female participants aged 18 to 75 with moderate to severe systemic lupus erythematosusSystemic Lupus Erythematosus2023-510340-20-00Glaxosmithkline Research & Development Limited6
尚未招募
2/3 期
Clinical trial to compare the efficacy of Haridradi decoction with Kutaj sunthi decoction in the management of piles.CTRI/2024/09/074466Tilak Ayurveda Mahavidyalaya80
招募中
2 期
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLCNCT07269782Shanghai Henlius Biotech60